In the current study, we tested the anti-proliferative and pro-apoptotic action of ABT888 on the melanoma cell line A375 resistant to B-RAF inhibitor (Dabrafenib) and on other melanoma cell lines. This evidence concerns the gene BRAF and melanoma.